Litcius/Paper detail

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton, Gabriela Alexe, Daniel A. Schaefer, Anna C. Geraghty, Amanda L. Robichaud, Amy Saur Conway, Delan Khalid, Marius Marc-Daniel Mader, Julia A. Belk, Kenneth N. Ross, Michal Sheffer, Miles H. Linde, Nghi Ly, Winnie Yao, Maria Caterina Rotiroti, Benjamin Smith, Marius Wernig, Carolyn R. Bertozzi, Michelle Monje, Constantine S. Mitsiades, Ravindra Majeti, Ansuman T. Satpathy, Kimberly Stegmaier, Robbie G. Majzner

2022Nature Cancer110 citationsDOIOpen Access PDF

Topics & Concepts

NeuroblastomaMesenchymal stem cellAntibodyCancer researchDownregulation and upregulationBiologyMedicineImmunologyMolecular biologyCell cultureCell biologyBiochemistryGeneticsGeneNeuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismUbiquitin and proteasome pathways
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1 | Litcius